HAVCR2 and B-cell chronic lymphocytic leukemia: TIM-3 is highly expressed in peripheral blood and bone marrow exhausted T cells in a variety of hematological malignancies, including acute lymphoblastic leukemia (ALL), chronic lymphocytic leukemia (CLL), and multiple myeloma (MM) (57, 77, 85).